HealthyWay Inc. disclosed that it repurchased 137,000 ordinary shares on 15 April 2026 via on-market transactions at prices ranging from HKD 4.68 to HKD 4.69 per share, for a total consideration of HKD 0.64 million.

Following the repurchase, the company’s outstanding shares (excluding treasury stock) declined by 0.016 % to 874.85 million, while treasury shares increased to 2.85 million. Total issued shares, inclusive of treasury stock, remained unchanged at 877.70 million.

Under the general mandate granted on 3 June 2025, HealthyWay is authorised to buy back up to 87.77 million shares. Cumulative repurchases under this mandate now stand at 2.85 million shares, equivalent to 0.33 % of the shares outstanding at the mandate date.

A 30-day moratorium on issuing new shares or disposing of treasury shares will be in effect until 14 May 2026, in accordance with Hong Kong Stock Exchange regulations.